(NASDAQ:BFRI),(NASDAQ:BFRIW), sNDA for treatment of sBCC with Ameluz(R)-PDT submitted to U.S. Food and Drug Administration (FDA) on November 28, 2025 First Phase 3 PDT study in patients with sBCC in the United States submitted to FDA Primary and key secondary endpoints met with high statistical significance (p <0.0001) Favorable recurrence outcomes at one-year follow-up BCC […]

(CNSX:BLO.CN),(Pinksheets:BLOZF),(PinkSheets:BLOZF),(CNSX:BLO),(Boerse Frankfurt – Freiverkehr:8CT), VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to announce that it has entered into a second sales agreement for its BreathLogix unmanned alcohol screening technology with an

(NASDAQ:PALI), Veteran gastroenterologist and clinical development leader with deep expertise driving global Phase 2/3 programs across immunology, neurology, and gastrointestinal disease Carlsbad, CA, Dec. 02, 2025 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade” or the “Company”), a clinical-stage biopharmaceutical company advancing next-generation, once daily, oral PDE4 inhibitor prodrugs for patients with inflammatory and fibrotic

PARADISE VALLEY, Ariz., Dec. 02, 2025 (GLOBE NEWSWIRE) — Semiconductor manufacturer, IceMOS Technology Corporation , today announced a significant expansion of its global footprint with the establishment of IceMOS Technology Hong Kong Limited within the prestigious Hong Kong Science Park. This strategic move provides robust regional support for sales, field applications engineering and supply chain

Cannabix Technologies Strengthens Presence in Maritime Market with Repeat BreathLogix Alcohol Screening Device Order GlobeNewswire December 02, 2025 VANCOUVER, British Columbia, Dec. 02, 2025 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTCID: BLOZF) (Frankfurt: 8CT) (the “Company or Cannabix”) developer of marijuana and alcohol breath devices is pleased to announce that it has entered

Palisade Bio Strengthens Clinical Leadership Team with Appointment of James Izanec, MD, AGAF as Vice President, Clinical Development GlobeNewswire December 02, 2025 Veteran gastroenterologist and clinical development leader with deep expertise driving global Phase 2/3 programs across immunology, neurology, and gastrointestinal disease Carlsbad, CA, Dec. 02, 2025 (GLOBE NEWSWIRE) — Palisade Bio, Inc. (Nasdaq: PALI) (“Palisade”

Gulf Resources, Inc. Regains Compliance with Nasdaq Listing Requirements GlobeNewswire December 02, 2025 SHOUGUANG, China, Dec. 02, 2025 (GLOBE NEWSWIRE) — Gulf Resources, Inc. (“Gulf Resources,” “we,” or the “Company”) announced today that it received notification from the Listing Qualifications Department of The Nasdaq Stock Market LLC (“Nasdaq”) that the Company has regained compliance with

IceMOS Technology Accelerates Global Expansion with Strategic Hong Kong Science Park Office GlobeNewswire December 02, 2025 PARADISE VALLEY, Ariz., Dec. 02, 2025 (GLOBE NEWSWIRE) — Semiconductor manufacturer, IceMOS Technology Corporation , today announced a significant expansion of its global footprint with the establishment of IceMOS Technology Hong Kong Limited within the prestigious Hong Kong Science

Biofrontera Inc. Announces Filing of Supplemental New Drug Application (sNDA) for the Treatment of Superficial Basal Cell Carcinoma (sBCC) with Ameluz(R)-PDT GlobeNewswire December 02, 2025 sNDA for treatment of sBCC with Ameluz(R)-PDT submitted to U.S. Food and Drug Administration (FDA) on November 28, 2025 First Phase 3 PDT study in patients with sBCC in the

Personal Lubricants Market Set to Reach USD 3.30 Billion by 2032, at 9.5% CAGR, says Coherent Market Insights GlobeNewswire December 02, 2025 Burlingame, CA, Dec. 02, 2025 (GLOBE NEWSWIRE) — The Global Personal Lubricants Market is estimated to be valued at USD 1.75 Bn in 2025 and is expected to reach USD 3.30 Bn by